Biogen (BIIB) Income After Tax (2009 - 2026)
Biogen (BIIB) posted Income After Tax of -$20.6 million for Q3 2026, compared with $466.5 million a year earlier.
Powered by 
Analysis
Biogen (BIIB) Income After Tax (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Income After Tax at Biogen was $347.5 million, down 78.4% year-over-year; for FY2025, it came in at $1.29 billion, down 20.8% from FY2024.
- Annual Income After Tax shows a five-year compound annual growth rate of -20.4% (FY2020 to FY2025).
- In prior years, Biogen's Income After Tax was $1.63 billion in FY2024 (+40.5%), $1.16 billion in FY2023 (-60.7%), $2.96 billion in FY2022 (+74.8%) and $1.69 billion in FY2021 (-58.3%).
- Quarterly Income After Tax has run from a low of -$68.3 million in Q3 2023 to a high of $1.13 billion in Q3 2022 over five years.
- On a year-over-year basis, Income After Tax increased in four of the last six quarters, with an average decline of 9.1%.
- The strongest year-over-year quarter for Income After Tax in the past five years was Q3 2022, with growth of 258.0%; the weakest was Q2 2026, with a decline of 84.6%.
- According to Business Quant data, Income After Tax for the three prior quarters was $97.5 million (Q2 2026), $319.5 million (Q1 2026) and -$48.9 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn | -20.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -20.60 Mn |
| Jun 30, 2026 | 97.50 Mn |
| Mar 31, 2026 | 319.50 Mn |
| Dec 31, 2025 | -48.90 Mn |
| Sep 30, 2025 | 466.50 Mn |
| Jun 30, 2025 | 634.80 Mn |
| Mar 31, 2025 | 240.50 Mn |
| Dec 31, 2024 | 266.70 Mn |
| Sep 30, 2024 | 388.50 Mn |
| Jun 30, 2024 | 583.60 Mn |
| Mar 31, 2024 | 393.40 Mn |
| Dec 31, 2023 | 248.90 Mn |
| Sep 30, 2023 | -68.30 Mn |
| Jun 30, 2023 | 593.30 Mn |
| Mar 31, 2023 | 387.60 Mn |
| Dec 31, 2022 | 549.50 Mn |
| Sep 30, 2022 | 1.13 Bn |
| Jun 30, 2022 | 1.05 Bn |
| Mar 31, 2022 | 221.80 Mn |
| Dec 31, 2021 | -38.20 Mn |
API Access
Biogen Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();